Sclerostin and Vascular Pathophysiology.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Jul 2020
Historique:
received: 23 05 2020
revised: 26 06 2020
accepted: 03 07 2020
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 9 3 2021
Statut: epublish

Résumé

There is cumulating evidence for a contribution of Wnt signaling pathways in multiple processes involved in atherosclerosis and vascular aging. Wnt signaling plays a role in endothelial dysfunction, in the proliferation and migration of vascular smooth muscle cells (VSMCs) and intimal thickening. Moreover, it interferes with inflammation processes, monocyte adhesion and migration, as well as with foam cell formation and vascular calcification progression. Sclerostin is a negative regulator of the canonical Wnt signaling pathway and, accordingly, the consequence of increased sclerostin availability can be disruption of the Wnt signalling cascade. Sclerostin is becoming a marker for clinical and subclinical vascular diseases and several lines of evidence illustrate its role in the pathophysiology of the vascular system. Sclerostin levels increase with aging and persist higher in some diseases (e.g., diabetes, chronic kidney disease) that are known to precipitate atherosclerosis and enhance cardiovascular risk. Current knowledge on the association between sclerostin and vascular diseases is summarized in this review.

Identifiants

pubmed: 32640551
pii: ijms21134779
doi: 10.3390/ijms21134779
pmc: PMC7370046
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Biomarkers 0
SOST protein, human 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Ren Fail. 2016 Jun;38(5):759-64
pubmed: 27001371
Physiol Rev. 2004 Jul;84(3):767-801
pubmed: 15269336
Aging Cell. 2011 Apr;10(2):220-32
pubmed: 21108734
Ren Fail. 2020 Nov;42(1):282-288
pubmed: 32216514
Nephrol Dial Transplant. 2015 Feb;30(2):288-93
pubmed: 25248363
Mol Cell Proteomics. 2011 Aug;10(8):M111.008128
pubmed: 21593211
Int Urol Nephrol. 2016 Dec;48(12):2029-2042
pubmed: 27497736
J Clin Endocrinol Metab. 2014 Jan;99(1):315-21
pubmed: 24178795
J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61
pubmed: 25057883
Nephrol Ther. 2014 Nov;10(6):463-70
pubmed: 25070604
Atherosclerosis. 2015 Mar;239(1):218-23
pubmed: 25618029
Diabetes Metab. 2017 Sep;43(4):375-377
pubmed: 28277306
J Clin Endocrinol Metab. 2012 May;97(5):1737-44
pubmed: 22399511
Sci Rep. 2014 Mar 27;4:4493
pubmed: 24670389
J Clin Endocrinol Metab. 2012 Oct;97(10):3744-50
pubmed: 22855334
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Osteoporos Int. 2015 Aug;26(8):2165-74
pubmed: 25910747
J Bone Miner Metab. 2016 Sep;34(5):540-6
pubmed: 26204844
J Bone Miner Res. 2012 Aug;27(8):1757-72
pubmed: 22492547
N Engl J Med. 2016 Oct 20;375(16):1532-1543
pubmed: 27641143
Eur J Cell Biol. 2011 Jun-Jul;90(6-7):553-9
pubmed: 21185106
Cardiovasc Res. 2004 Sep 1;63(4):731-8
pubmed: 15306229
Bone. 2020 Jan;130:115121
pubmed: 31678488
Nat Rev Rheumatol. 2011 Sep 20;7(11):631-8
pubmed: 21931340
Hum Mol Genet. 2001 Mar 1;10(5):537-43
pubmed: 11181578
Bone. 2013 Sep;56(1):42-7
pubmed: 23702386
Eur J Endocrinol. 2008 Nov;159(5):603-8
pubmed: 18697793
Circ Res. 2010 Oct 15;107(8):943-52
pubmed: 20947863
Biomark Med. 2016 Jul;10(7):689-99
pubmed: 27347702
Circ Res. 2006 Dec 8;99(12):1329-37
pubmed: 17122440
Ageing Res Rev. 2016 Aug;29:90-112
pubmed: 27353257
J Clin Endocrinol Metab. 2014 Jan;99(1):248-55
pubmed: 24187403
Calcif Tissue Int. 2008 Aug;83(2):112-20
pubmed: 18612580
Nephron. 2016;132(3):181-90
pubmed: 26890570
J Endocrinol Invest. 2012 Oct;35(9):866-8
pubmed: 22842667
Organogenesis. 2008 Apr;4(2):68-75
pubmed: 19279717
Int Urol Nephrol. 2019 Feb;51(2):311-323
pubmed: 30515734
Bone. 2019 Jun;123:191-195
pubmed: 30910600
Diabetes Metab Res Rev. 2019 Jan;35(1):e3069
pubmed: 30144272
Medicine (Baltimore). 2016 Apr;95(15):e3300
pubmed: 27082570
PLoS One. 2011;6(5):e19595
pubmed: 21611184
Intern Emerg Med. 2017 Oct;12(7):915-921
pubmed: 28780668
Eur Heart J. 2011 Nov;32(22):2841-50
pubmed: 21398644
Bone. 2017 Mar;96:24-28
pubmed: 27742501
Trends Endocrinol Metab. 2012 Dec;23(12):628-36
pubmed: 22902904
J Immunol. 2010 Jul 15;185(2):1274-82
pubmed: 20554957
Pediatr Nephrol. 2016 Feb;31(2):195-206
pubmed: 25735207
J Heart Valve Dis. 2013 May;22(3):317-25
pubmed: 24151757
J Cell Biol. 2011 May 2;193(3):431-3
pubmed: 21536746
Diab Vasc Dis Res. 2014 Jan;11(1):48-52
pubmed: 24227537
Bone. 2013 Nov;57(1):272-6
pubmed: 23981659
Trends Genet. 2000 Jul;16(7):279-83
pubmed: 10858654
Mol Med Rep. 2017 May;15(5):3420-3424
pubmed: 28339088
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2864-70
pubmed: 18456733
Nature. 2011 May 19;473(7347):317-25
pubmed: 21593864
BMC Nephrol. 2018 Oct 12;19(1):264
pubmed: 30314461
J Clin Endocrinol Metab. 2013 May;98(5):1911-5
pubmed: 23596142
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):553-566
pubmed: 28062506
Curr Opin Lipidol. 2011 Oct;22(5):350-7
pubmed: 21841485
Diabetes Care. 2013 Jun;36(6):1667-74
pubmed: 23288857
Blood. 2006 Aug 1;108(3):965-73
pubmed: 16601243
Atherosclerosis. 2014 Nov;237(1):155-62
pubmed: 25240110
Bone. 2012 Mar;50(3):739-42
pubmed: 22178539
Nat Rev Endocrinol. 2017 Dec;13(12):697-698
pubmed: 29027994
Int J Mol Sci. 2019 Nov 06;20(22):
pubmed: 31698687
Curr Atheroscler Rep. 2009 May;11(3):236-42
pubmed: 19361356
Bone. 2018 Nov;116:42-46
pubmed: 30010081
Int Rev Cell Mol Biol. 2015;314:117-48
pubmed: 25619716
Circ Res. 2018 Sep 14;123(7):849-867
pubmed: 30355080
Eur J Endocrinol. 2014 Sep;171(3):293-300
pubmed: 24891138
J Clin Endocrinol Metab. 2013 Aug;98(8):3221-8
pubmed: 23788689
Clin J Am Soc Nephrol. 2013 May;8(5):819-23
pubmed: 23430206
Eur J Echocardiogr. 2011 Jul;12(7):528-35
pubmed: 21685195
Kidney Blood Press Res. 2014;39(4):230-9
pubmed: 25118597
J Bone Miner Res. 2013 Dec;28(12):2523-34
pubmed: 23703894
Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1228-34
pubmed: 19498175
Nutr Metab Cardiovasc Dis. 2011 Feb;21(2):150-6
pubmed: 19833493
Science. 2007 Mar 2;315(5816):1278-82
pubmed: 17332414

Auteurs

Antonino Catalano (A)

Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
A.O.U. Policlinico "G.Martino", Via Consolare Valeria, 98125 Messina, Italy.

Federica Bellone (F)

Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
A.O.U. Policlinico "G.Martino", Via Consolare Valeria, 98125 Messina, Italy.

Nunziata Morabito (N)

Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
A.O.U. Policlinico "G.Martino", Via Consolare Valeria, 98125 Messina, Italy.

Francesco Corica (F)

Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
A.O.U. Policlinico "G.Martino", Via Consolare Valeria, 98125 Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH